Why Join Intellia?Ā
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.Ā
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.Ā
We wantĀ all ofĀ our people to go beyond what is possible. We arenāt constrained by typical end rails, and we arenāt out to just ātreatā people. Weāre all in this for something more. Weāre driven to cure and motivated for change. Just imagine the possibilities of what we can do together.Ā Ā Ā
How You Will Achieve More:
We are seeking an exceptional Sales Representative to lead the commercial launch of our groundbreaking in vivo CRISPR therapy for hereditary angioedema (HAE). This roleĀ representsĀ aĀ career definingĀ opportunity to pioneer the commercializationĀ of the first-ever, single treatment gene editing therapy. The successful candidate willĀ be responsible forĀ introducing healthcare providers to the first-ever in vivo CRISPR therapy, requiring sophisticated scientific communication, complex stakeholder management, and exceptional execution within a highly competitive rare disease market.Ā
This territory will cover California and Hawaii.
Responsibilities:
Territory Management & Account DevelopmentĀ
- Territory Planning: Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centersĀ
- Account Prioritization: Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilitiesĀ
- Relationship Building: Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makersĀ
- Pipeline Management: Maintain robust sales pipeline tracking opportunities from initial awareness through patient treatment completionĀ
Scientific Education & CommunicationĀ
- CRISPR Technology Education: Educate healthcare providers on in vivo CRISPR gene editing mechanisms, differentiating from ex vivo cell therapies and traditional treatmentsĀ
- MOA Differentiation: Clearly articulate the unique mechanism of action compared to prophylactic treatments, complement inhibitors, and plasma-derived therapiesĀ
- Clinical Data Presentation: Present Phase III efficacy and safety dataĀ
- Technology Positioning: Address misconceptions about CRISPR safety and differentiate from previous gene therapy launchesĀ
- Disease Education:Ā educateĀ healthcare providers about unmet needs affecting disease management and treatment burdenĀ
Competitive DifferentiationĀ
- Competitive Intelligence: Maintain deep understanding of competitive landscape and emerging therapiesĀ
- Value Proposition Development: Articulate differentiated value propositions versus existing HAE treatments and other gene therapiesĀ
- Objection Handling: Proactively address concerns about CRISPR technology, permanent genetic modification, and single-treatment costĀ
- **Company Differentiation**: Position organization as innovative leader with superior clinicalĀ acumenĀ
Complex Treatment Pathway ManagementĀ
- Patient JourneyĀ Education:Ā Educate on theĀ patient pathway from diagnosis confirmation through treatment administrationĀ
- Hub Services Integration:Ā CoordinateĀ with patient support hubs to ensure seamless patient experience and treatment accessĀ
Cross-Functional CollaborationĀ
- Medical Affairs Partnership: Coordinate with Medical Science LiaisonsĀ to seamlessly address customersā medical and clinical informational needsĀ
- Market Access Alignment: Work closely with Field Reimbursement Managers on payer strategy andĀ coverage optimizationĀ
- Strategic Accounts:Ā Ā PartnerĀ with strategic accounts team to understand referral patterns, site selection, and site activation for procurement and administration of the therapyĀ
About You:
Scientific & Technical KnowledgeĀ
- HAE Understanding: Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet medical needsĀ
- CRISPR/Gene Therapy Familiarity: Understanding of gene editing technologies, genetic medicines, and regulatory requirementsĀ
- **Clinical Data Interpretation**: Ability to analyze and present complex clinical trial data and real-world evidenceĀ
Skills & CompetenciesĀ
- Scientific Communication: Exceptional ability to communicate complex scientific concepts to diverse healthcare audiencesĀ
- Customer Alignment &Ā Relationship Management: Proven ability to build andĀ maintainĀ long-term relationships with key stakeholdersĀ
- Problem Solving: Creative approach to overcoming access barriers and treatment implementation challengesĀ
- Collaboration and Learning: nurtures internal relationships andĀ facilitatesĀ collaborationĀ toĀ establishĀ trust and support from others.Ā Ā
- Growth Mindset: Remain open to change andĀ demonstratesĀ a willingness to tryĀ new approachesĀ to achieve better resultsĀ
- Competitive Mindset: Engages in bold conversations, handles objections, and asks forĀ the businessĀ
- Execution and Results:Ā DemonstratesĀ a businessĀ ownerĀ mindset andĀ takes action to exceedĀ expectations. Develops andĀ executes onĀ a comprehensiveĀ business plan to maximize customer and patient impactĀ
Personal AttributesĀ
- Innovation Mindset: Passion for pioneering new treatment paradigms and improving patient outcomesĀ
- Resilience: Ability to persist through lengthy sales cycles and overcome technology-related objectionsĀ
- Adaptability: Flexibility to adjust strategies based on market feedback and competitive dynamicsĀ
- Integrity: Unwavering commitment to ethical sales practices and regulatory complianceĀ
- Patient Focus: Genuine commitment to improving lives of patients with rare genetic diseasesĀ
- BS/BA in life sciences or a business-related fieldĀ
- Rare Disease, Gene therapy, and HAE market knowledge preferred but not necessaryĀ
- Sales Experience: 5+ years of specialty pharmaceutical sales experience, preferably in rare diseases, immunology, or genetic medicinesĀ
- Rare Disease Expertise: Proven track record in rare disease commercialization with complex treatment paradigms and small patient populationsĀ
- Launch Experience: Previous experience with product launches, particularly first-in-class or novel mechanism therapiesĀ
- Complex Sales Environment: Demonstrated success in long sales cycles (12-18 months) with multiple stakeholders and high-value transactionsĀ
#LI-Remote
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down.
The base salary for this position is expected to range between $166,500.00 - $203,500.00 USD per year.The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors.
Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Companyās discretion.
For more information about Intelliaās benefits, please click here.
Learn more about this Employer on their Career Site
